Search

Potato starch (PS), also one amylose-rich starch (high amylose maize starch, HAMS) and one amlyopectin-rich starch (waxymaize starch, WMS) were used for the syntheses as raw materials. Starch acetates were synthesized by reaction with acetic acid anhydride and potassium carbonate as activator. Tests of thermoplastic processability of the starch acetates were performed by extrusion followed by injection molding to specimens. Glycerine triacetate (triacetin, TAc) was attached as plasticizer to starch acetate. For this system a processing procedure was acquired under variation of different parameters. Starch- and cellulose-based films containing inorganic luminescent quantum dots, namely europium doped yttrium vanadate (YVO4:Eu) and cerium and terbium doped lanthanum phosphate (LaPO4:Ce,Tb) as well as an organic laser dye (naphthaldiimide, LV 570) were prepared by tape casting and air brush technique. Under UV-light exposure, they show a bright fluorescence radiation depending on the incorporate dye or quantum dot.

Summary A series of seven patients with the polymyalgia rheumatica-temporal arteritis (RMR-TA) complex is presented, each of whom during the clinical course demonstrated the presence of anticardiolipin antibodies (ACLs). Presenting symptoms consisted of proximal myalgias and stiffness characteristic of PMR in five patients and of visual symptoms and headache suspicious for TA in two patients. Two of the five PMR patients later developed jaw claudication characteristic of TA. Six of the seven cases demonstrated clinical evidence of a vasculopathic process such as a cerebrovascular infarct or a vasculitic syndrome. Previous studies have suggested an association between ACLs and PMR-TA, and this series of patients appears to provide more supporting evidence. Even patients who only manifested PMR symptoms without suggestion of accompanying TA developed vascular complications. An increasing range of symptoms have been recognized in association with ACLs, and the vasculitic syndromes of PMR-TA should be included as a possible association. While this series together with previous studies may suggest that the presence of ACLs in patients with PMR-TA symptoms may serve as a marker for the development of vascular complications, larger longitudinal studies will be necessary in the future.

von Willebrand factor (vWF) was purified from pooled normal plasma, radiolabeled with iodine then cleaved by porcine pancreatic elastase. Cleavage was monitored by sodium dodecylsulphate-polyacrylamide gel electrophoresis (SDS-PAGE), SDS-agarose electrophoresis, crossed immuno- electrophoresis, ristocetin and botrocetin cofactor activities, and ristocetin and botrocetin induced binding to fixed washed platelets. Cleavage of vWF by porcine elastase was dependent on both the concentration of porcine elastase and period of incubation. Incubation of vWF with concentrations of porcine elastase greater than 20 U/mL for 30 minutes resulted in loss of the 240 Kd vWF subunit and a corresponding loss of the high molecular weight multimers and formation of fragments with molecular weights on reduced SDS-PAGE of 150, 125, 115 Kd and minor bands at 44, 28, and 24 Kd and a band at 20 Kd, which increased in intensity as either the concentration of porcine elastase or the period of incubation increased. More than 50% of the ristocetin cofactor activity was lost during a five-minute incubation of vWF with 0.56 U/mL porcine elastase when no detectable structural changes in the vWF molecule had occurred. Botrocetin cofactor activity was more resistant. Similarly botrocetin induced vWF binding to platelets was retained by a fraction produced by digestion of vWF with porcine elastase, which contained predominantly a 20 Kd fragment of vWF. This fragment retained insignificant amounts of ristocetin related functions and therefore represents a useful piece of the vWF molecule for further exploration of the site involved in botrocetin induced binding to platelets.

Beside the well-known evidences of the additional cardiovascular risk linked to a chronic increase of the pressure values, it is also likely that their variability may play a role as a risk factor. The blood pressure variability (BPV) is usually estimated using the Standard Deviation (SD) from the mean; our study allowed to elaborate a new method to assess the BPV as the average of the absolute difference between subsequent blood pressure measures; this method of calculating BPV was applied to the BP values measured routinely with standard ambulatory blood pressure monitoring (ABPM).